Bridgeway Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,300
| Closed | -$605K | – | 1301 |
|
|
2024
Q3 | $605K | Hold |
1,300
| – | – | 0.01% | 817 |
|
|
2024
Q2 | $609K | Sell |
1,300
-6,100
| -82% | -$2.86M | 0.01% | 820 |
|
|
2024
Q1 | $3.09M | Sell |
7,400
-5,900
| -44% | -$2.47M | 0.06% | 433 |
|
|
2023
Q4 | $5.41M | Sell |
13,300
-8,000
| -38% | -$3.26M | 0.12% | 282 |
|
|
2023
Q3 | $7.41M | Sell |
21,300
-7,050
| -25% | -$2.45M | 0.18% | 174 |
|
|
2023
Q2 | $9.98M | Hold |
28,350
| – | – | 0.24% | 116 |
|
|
2023
Q1 | $8.93M | Buy |
28,350
+2,700
| +11% | +$851K | 0.24% | 108 |
|
|
2022
Q4 | $7.41M | Hold |
25,650
| – | – | 0.19% | 165 |
|
|
2022
Q3 | $7.43M | Buy |
+25,650
| New | +$7.43M | 0.2% | 145 |
|
|
2021
Q1 | – | Sell |
-16,610
| Closed | -$3.93M | – | 1417 |
|
|
2020
Q4 | $3.93M | Hold |
16,610
| – | – | 0.08% | 301 |
|
|
2020
Q3 | $4.52M | Buy |
16,610
+2,660
| +19% | +$724K | 0.1% | 216 |
|
|
2020
Q2 | $4.05M | Buy |
13,950
+3,480
| +33% | +$1.01M | 0.08% | 235 |
|
|
2020
Q1 | $2.49M | Buy |
+10,470
| New | +$2.49M | 0.06% | 275 |
|
|
2019
Q2 | – | Sell |
-7,000
| Closed | -$1.29M | – | 1395 |
|
|
2019
Q1 | $1.29M | Sell |
7,000
-13,200
| -65% | -$2.43M | 0.02% | 668 |
|
|
2018
Q4 | $3.35M | Sell |
20,200
-29,100
| -59% | -$4.82M | 0.04% | 297 |
|
|
2018
Q3 | $9.5M | Hold |
49,300
| – | – | 0.09% | 182 |
|
|
2018
Q2 | $8.38M | Hold |
49,300
| – | – | 0.09% | 195 |
|
|
2018
Q1 | $8.04M | Hold |
49,300
| – | – | 0.09% | 182 |
|
|
2017
Q4 | $7.39M | Hold |
49,300
| – | – | 0.08% | 209 |
|
|
2017
Q3 | $7.5M | Buy |
49,300
+7,800
| +19% | +$1.19M | 0.09% | 200 |
|
|
2017
Q2 | $5.35M | Buy |
+41,500
| New | +$5.35M | 0.06% | 237 |
|